FDA Inspection 1169144 — Ortek Therapeutics, Inc.
The FDA completed an inspection of Ortek Therapeutics, Inc. on May 4, 2022 in Roslyn Heights, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Roslyn Heights, NY (United States)